INTRAVESICAL GEMCITABINE IN COMBINATION WITH MITOMYCIN C AS SALVAGE TREATMENT IN RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Cockerill, Patrick
Knoedler, John
Karnes, Robert
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2874
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1784
引用
收藏
页码：E733 / E733
页数：1
相关论文
共 50 条
  • [21] Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review
    Shelley, Mike D.
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm D.
    Kynaston, Howard G.
    BJU INTERNATIONAL, 2012, 109 (04) : 496 - 505
  • [22] INTRAVESICAL THERAPY FOLLOWING TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Wang, Wei
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 36 - 36
  • [23] Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer
    Weintraub, Michael D.
    Li, Qingdi Quentin
    Agarwal, Piyush K.
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 656 - 660
  • [24] Intravesical chemohyperthermia with mitomycin c for intermediate- & high-risk non-muscle invasive bladder cancer
    Lai, B. C. H.
    Wen, Y. -C.
    Shih, H. -J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 13 - 13
  • [25] Intravesical Electromotive Drug Administration (R) (EMDA) with Mitomycin-C for non-muscle invasive bladder cancer
    Di Stasi, S. M.
    Dutto, L.
    Verri, C.
    UROLOGIA JOURNAL, 2008, 75 (04) : 214 - 220
  • [26] Outcomes of maintenance intravesical mitomycin C and BCG instillation in intermediate risk non-muscle invasive bladder cancer
    Pun, C. T.
    Kan, C. F.
    Au, W. H.
    BJU INTERNATIONAL, 2015, 115 : 3 - 3
  • [27] Maintenance intravesical mitomycin C efficacy in intermediate risk non-muscle invasive bladder cancer: prospective cohort
    Li, T. C. F.
    Kan, C. F.
    Au, W. H.
    BJU INTERNATIONAL, 2017, 119 : 14 - 14
  • [28] Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
    Milbar, Niv
    Kates, Max
    Chappidi, Meera R.
    Pederzoli, Filippo
    Yoshida, Takahiro
    Sankin, Alexander
    Pierorazio, Phillip M.
    Schoenberg, Mark P.
    Bivalacqua, Trinity J.
    BLADDER CANCER, 2017, 3 (04) : 293 - 303
  • [29] Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial
    Rongxin Li
    Ye Li
    Jun Song
    Ke Gao
    Kangning Chen
    Xiaogang Yang
    Yongqiang Ding
    Xinlong Ma
    Yang Wang
    Weipeng Li
    Yanan Wang
    Zhiping Wang
    Zhilong Dong
    BMC Urology, 20
  • [30] Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial
    Li, Rongxin
    Li, Ye
    Song, Jun
    Gao, Ke
    Chen, Kangning
    Yang, Xiaogang
    Ding, Yongqiang
    Ma, Xinlong
    Wang, Yang
    Li, Weipeng
    Wang, Yanan
    Wang, Zhiping
    Dong, Zhilong
    BMC UROLOGY, 2020, 20 (01)
12345